Stem Cell Reviews and Reports

Papers
(The H4-Index of Stem Cell Reviews and Reports is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement306
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future229
SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome116
Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?89
Is COVID-19 a New Hematologic Disease?71
Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-1970
A Brief Overview of Global Trends in MSC-Based Cell Therapy69
Specificity of 3D MSC Spheroids Microenvironment: Impact on MSC Behavior and Properties63
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Accelerate Cutaneous Wound Healing by Enhancing Angiogenesis through Delivering Angiopoietin-258
Review of the Current Trends in Clinical Trials Involving Induced Pluripotent Stem Cells55
Immunosuppressive Effects of Mesenchymal Stem Cells-derived Exosomes54
Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein52
Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Treatment of Diabetic Foot Ulcers: Application and Challenges51
Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility51
Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises49
Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics49
Telomeres and Mitochondrial Metabolism: Implications for Cellular Senescence and Age-related Diseases48
Delivery of miR-381-3p Mimic by Mesenchymal Stem Cell-Derived Exosomes Inhibits Triple Negative Breast Cancer Aggressiveness; an In Vitro Study48
SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism48
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes for Orthopedic Diseases Treatment47
Regenerative Potential of DPSCs and Revascularization: Direct, Paracrine or Autocrine Effect?45
Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Facilitate Diabetic Wound Healing Through MiR-17-5p-mediated Enhancement of Angiogenesis43
Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs42
Recent Progress in Engineering Mesenchymal Stem Cell Differentiation42
Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects38
Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer’s Disease37
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells37
A Review on Mesenchymal Stem Cells for Treatment of Retinal Diseases37
An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner35
Extracellular Matrix Remodeling and Development of Cancer34
Mesenchymal Stem Cell Derived Exosomes Suppress Neuronal Cell Ferroptosis Via lncGm36569/miR-5627-5p/FSP1 Axis in Acute Spinal Cord Injury34
Nlrp3 Inflammasome Signaling Regulates the Homing and Engraftment of Hematopoietic Stem Cells (HSPCs) by Enhancing Incorporation of CXCR4 Receptor into Membrane Lipid Rafts33
Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia33
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis33
0.067553997039795